Patent details

Basic Information

Publication number:

EP3212670

PCT Application Number:

US2015057781

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP157982646

PCT Publication Number:

WO2016069727

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY FOR CANCER

French Title of Invention:

POLYTHÉRAPIE CONTRE LE CANCER

German Title of Invention:

KOMBINATIONSTHERAPIE GEGEN KREBS

SPC Number:

Dates

Filing date:

28/10/2015

Grant date:

23/12/2020

EP Publication Date:

06/09/2017

PCT Publication Date:

06/05/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/12/2020

EP B1 Publication Date:

23/12/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/10/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/12/2020

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Name:

Five Prime Therapeutics, Inc.

Address:

111 Oyster Point Boulevard, South San Francisco, CA 94080, United States (US)

Agent

Name:

MARKS & CLERK LLP

From:

04/01/2021

Address:

BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

HESTIR, Kevin

Address:

United States (US)

2

Name:

MASTELLER, Emma

Address:

United States (US)

3

Name:

WONG, Brian

Address:

United States (US)

4

Name:

HAMBLETON, Julie

Address:

United States (US)

5

Name:

SIKORSKI, Robert

Address:

United States (US)

6

Name:

BELLOVIN, David

Address:

United States (US)

7

Name:

LEWIS, Katherine E.

Address:

United States (US)

Priority

1

Priority Number:

201462072035 P

Priority Date:

29/10/2014

Priority Country:

United States (US)

2

Priority Number:

201562157368 P

Priority Date:

05/05/2015

Priority Country:

United States (US)

3

Priority Number:

201562192025 P

Priority Date:

13/07/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; A61P 35/00; C07K 16/28;

Publication

European Patent Bulletin

Issue number:

202052

Publication date:

23/12/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/04/2025

Annual Fee Number:

10

Annual Fee Amount:

131 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

11/10/2023

Last Annual Fee Paid Number:

9

Last Annual Fee Paid Amount:

115 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
04/01/2021	Power Of Attorney	1
05/01/2021	Outgoing Correspondence	1
12/08/2022	Request For Change	1
02/09/2022	Outgoing Correspondence	56
03/03/2025	Incoming Correspondence (Post)	2